おすすめの製品
由来生物
rabbit
品質水準
100
500
結合体
unconjugated
抗体製品の状態
culture supernatant
抗体製品タイプ
primary antibodies
クローン
EP212, monoclonal
詳細
For In Vitro Diagnostic Use in Select Regions (See Chart)
フォーム
buffered aqueous solution
交差性
human
包装
vial of 0.1 mL concentrate (386R-14)
vial of 0.5 mL concentrate (386R-15)
bottle of 1.0 mL predilute (386R-17)
vial of 1.0 mL concentrate (386R-16)
bottle of 7.0 mL predilute (386R-18)
メーカー／製品名
Cell Marque®
テクニック
immunohistochemistry (formalin-fixed, paraffin-embedded sections): 1:25-1:100
アイソタイプ
IgG
コントロール
rhabdomyosarcoma
輸送温度
wet ice
保管温度
2-8°C
視覚化
nuclear
遺伝子情報
human ... MYOD1(4654)
詳細
MyoD1, one of the MyoD family of myogenic helix-loop-helix transcription factors, combinedwith myogenin, plays a role in coordinating the differentiation of skeletal muscle. MyoD1 isexpressed in myoblasts before differentiation. Anti-MyoD1 immunostaining identifies cellscommitted to myogenesis in their earliest phase. In conjunction with other markers, antiMyoD1 may be used for the identification of rhabdomyosarcoma.
品質
 IVD |  IVD |  IVD |  RUO |
関連事項
MyoD1 Positive Control Slides, Product No. 386S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
物理的形状
Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
調製ノート
Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
その他情報
For Technical Service please contact: 800-665-7284 or email: service@cellmarque.com
法的情報
Cell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
最新バージョンのいずれかを選択してください：
試験成績書（COA）
Lot/Batch Number
N J Sebire et al.
Journal of clinical pathology, 56(6), 412-416 (2003-06-05)
The diagnosis of paediatric solid tumours is often based on small tissue needle biopsies in which many different entities demonstrate a "small round cell tumour" phenotype and in which there may be insufficient tissue to allow the interpretation of diagnostic
Raffaella A Morotti et al.
The American journal of surgical pathology, 30(8), 962-968 (2006-07-25)
Immunohistochemistry remains the current ancillary method of choice in the pathologic evaluation of small blue round-cell tumors. In at least 20% of cases of rhabdomyosarcoma (RMS), it is considered an essential factor in the final and/or differential diagnosis of the
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）